Literature DB >> 13814521

Hepatitis caused by glipasol (R.P. 2259)--an antidiabetic sulphonamide drug.

T W DAVIS, R B KERR, A BOGOCH.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/toxicology; HEPATITIS/etiology

Mesh：

Substances：

Year:  1960        PMID： 13814521      PMCID： PMC1938319     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

2.  SEROLOGICAL DIFFERENTIATION OF OBSTRUCTIVE FROM HEPATOGENOUS JAUNDICE BY FLOCCULATION OF CEPHALIN-CHOLESTEROL EMULSIONS.

Authors:  F M Hanger
Journal:  J Clin Invest       Date:  1939-05       Impact factor: 14.808

3.  The Pathology of Sulfonamide Allergy in Man.

Authors:  R H More; G C McMillan; G L Duff
Journal:  Am J Pathol       Date:  1946-07       Impact factor: 4.307

4.  A multiplicity of reactions to carbutamide (BZ-55) therapy; report of a case.

Authors:  J A TULLOCH
Journal:  Diabetes       Date:  1958 Jul-Aug       Impact factor: 9.461

5.  Clinical experience with carbutamide (BZ-55); a progress report.

Authors:  R CAMERINI-DAVALOS; A MARBLE; H F ROOT
Journal:  Diabetes       Date:  1957 Jan-Feb       Impact factor: 9.461

6.  Sudden death in a diabetic subject during treatment with BZ-55 (carbutamide).

Authors:  D D FEDERMAN; J B FIELD
Journal:  Diabetes       Date:  1957 Jan-Feb       Impact factor: 9.461
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.